PMC:7311890 / 11523-11843 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T96","span":{"begin":55,"end":62},"obj":"Body_part"},{"id":"T97","span":{"begin":83,"end":96},"obj":"Body_part"},{"id":"T98","span":{"begin":118,"end":129},"obj":"Body_part"},{"id":"T99","span":{"begin":169,"end":174},"obj":"Body_part"}],"attributes":[{"id":"A96","pred":"fma_id","subj":"T96","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A97","pred":"fma_id","subj":"T97","obj":"http://purl.org/sig/ont/fma/fma264829"},{"id":"A98","pred":"fma_id","subj":"T98","obj":"http://purl.org/sig/ont/fma/fma62845"},{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T11","span":{"begin":169,"end":174},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T73","span":{"begin":20,"end":32},"obj":"Disease"}],"attributes":[{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T90","span":{"begin":83,"end":96},"obj":"http://purl.obolibrary.org/obo/PR_000001393"},{"id":"T91","span":{"begin":118,"end":129},"obj":"http://purl.obolibrary.org/obo/CL_0000232"},{"id":"T92","span":{"begin":316,"end":318},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T102","span":{"begin":55,"end":62},"obj":"Chemical"},{"id":"T103","span":{"begin":98,"end":100},"obj":"Chemical"},{"id":"T105","span":{"begin":185,"end":187},"obj":"Chemical"}],"attributes":[{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A104","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A105","pred":"chebi_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/CHEBI_71029"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"395","span":{"begin":44,"end":62},"obj":"Gene"},{"id":"396","span":{"begin":64,"end":67},"obj":"Gene"},{"id":"397","span":{"begin":83,"end":96},"obj":"Gene"},{"id":"398","span":{"begin":98,"end":102},"obj":"Gene"},{"id":"407","span":{"begin":20,"end":32},"obj":"Disease"}],"attributes":[{"id":"A395","pred":"tao:has_database_id","subj":"395","obj":"Gene:1401"},{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"Gene:1401"},{"id":"A397","pred":"tao:has_database_id","subj":"397","obj":"Gene:3569"},{"id":"A398","pred":"tao:has_database_id","subj":"398","obj":"Gene:3569"},{"id":"A407","pred":"tao:has_database_id","subj":"407","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T27","span":{"begin":20,"end":32},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T69","span":{"begin":0,"end":320},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T282","span":{"begin":44,"end":62},"obj":"PR:000005897"},{"id":"T283","span":{"begin":64,"end":67},"obj":"PR:000005897"},{"id":"T284","span":{"begin":83,"end":96},"obj":"PR:000001393"},{"id":"T285","span":{"begin":98,"end":102},"obj":"PR:000001393"},{"id":"T286","span":{"begin":118,"end":129},"obj":"CL:0000232"},{"id":"T287","span":{"begin":169,"end":174},"obj":"UBERON:0001977"},{"id":"T19907","span":{"begin":50,"end":61},"obj":"CHEBI:26667;CHEBI:26667"},{"id":"T44302","span":{"begin":120,"end":125},"obj":"CHEBI:18059;CHEBI:18059"},{"id":"T19708","span":{"begin":158,"end":165},"obj":"NCBITaxon:10239"}],"text":"Indices of systemic inflammation, including C-reactive protein (CRP) (p = 0.0003), interleukin-6 (IL-6) (p = 0.0958), erythrocyte sedimentation rate (ESR) (p = 0.0008), serum ferritin (SF) (p = 0.0001), and procalcitonin (p = 0.0171), exhibited progressive increases as disease severity increased (Figure S1B; Table S1)."}